<DOC>
	<DOCNO>NCT01866150</DOCNO>
	<brief_summary>This cross-sectional , non-interventional , retrospective chart review compare efficacy safety biologic monotherapy biologic methotrexate combination therapy patient rheumatoid arthritis inadequate response prior treatment disease-modifying anti-rheumatic drug include methotrexate . Data collect patient first-line biologic treatment least 6 month .</brief_summary>
	<brief_title>A Retrospective , Observational Chart Review Biologics Monotherapy Versus Combination Biologic Plus Methotrexate Patients With Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>Adult patient , &gt; /= 18 year age Diagnosis rheumatoid arthritis rheumatologist Patients respond inadequately methotrexate diseasemodifying antirheumatic drug ( DMARDs ) prescribe biologic monotherapy combination methotrexate classical DMARDs per NICE guideline Primary diagnosis condition rheumatoid arthritis Current treatment biologic combination without methotrexate Prior treatment experimental agent rheumatoid arthritis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>